Ronald H. Gray
Karolinska University Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ronald H. Gray.
PLOS Pathogens | 2014
Taha Hirbod; Xiangrong Kong; Godgrey Kigozi; Anthony Ndyanabo; David Serwadda; Jessica L. Prodger; Aaron A. R. Tobian; Fred Nalugoda; Maria J. Wawer; Kamnoosh Shahabi; Olga L. Rojas; Jennifer L. Gommerman; Kristina Broliden; Rupert Kaul; Ronald H. Gray
Background The foreskin is the site of most HIV acquisition in uncircumcised heterosexual men. Although HIV-exposed, seronegative (HESN) uncircumcised men demonstrate HIV-neutralizing IgA and increased antimicrobial peptides (AMPs) in the foreskin prepuce, no prospective studies have examined the mucosal immune correlates of HIV acquisition. Methods To assess the association of foreskin immune parameters with HIV acquisition, antimicrobial peptides and IgA with the capacity to neutralize a primary clade C HIV strain were quantified by blinded investigators, using sub-preputial swabs collected longitudinally during a randomized trial of male circumcision for HIV prevention in Rakai, Uganda. Results Participants were 99 men who acquired HIV (cases) and 109 randomly selected controls who remained HIV seronegative. At enrollment, 44.4% of cases vs. 69.7% of controls demonstrated IgA neutralization (adjusted OR = 0.31; 95% CI, 0.16–0.61). IgA neutralization was detected in 38.7% of cases and 70.7% of controls at the last seronegative case visit prior to HIV acquisition and the comparable control visit (adjusted OR 0.21; 95% CI, 0.11–0.39). Levels of the α-defensins and secretory leukocyte protease inhibitor (SLPI) were over ten-fold higher in the foreskin prepuce of cases who acquired HIV, both at enrollment (mean 4.43 vs. 3.03 and 5.98 vs. 4.61 logn pg/mL, P = 0.005 and 0.009, respectively), and at the last seronegative visit (mean 4.81 vs. 3.15 and 6.46 vs. 5.20 logn pg/mL, P = 0.0002 and 0.013). Conclusions This prospective, blinded analysis is the first to assess the immune correlates of HIV acquisition in the foreskin. HIV-neutralizing IgA, previously associated with the HESN phenotype, was a biomarker of HIV protection, but other HESN associations correlated with increased HIV acquisition. This emphasizes the importance of prospective epidemiological studies or in vitro tissue studies to define the impact of mucosal parameters on HIV risk.
PLOS ONE | 2012
Minh H. Dinh; Taha Hirbod; Godfrey Kigozi; Eneniziaogochukwu A. Okocha; Gianguido C. Cianci; Xiangrong Kong; Jessica L. Prodger; Kristina Broliden; Rupert Kaul; David Serwadda; Maria J. Wawer; Ronald H. Gray; Thomas J. Hope
It has been hypothesized that increased HIV acquisition in uncircumcised men may relate to a more thinly keratinized inner foreskin. However, published data are contradictory and potentially confounded by medical indications for circumcision. We tested the hypothesis that the inner foreskin was more thinly keratinized than the outer foreskin using tissues from 19 healthy, HIV-uninfected men undergoing routine prophylactic circumcision in Rakai, Uganda. Sections from 3 foreskin anatomic sites (inner, outer, and frenar band) were snap-frozen separately. Two independent laboratories each separately stained, imaged, and measured keratin thicknesses in a blinded fashion. There was no significant difference in keratin thickness between the inner (mean = 14.67±7.48 µm) and outer (mean = 13.30±8.49 µm) foreskin, or between the inner foreskin and the frenar band (mean = 16.91±12.42 µm). While the frenar band showed the greatest intra-individual heterogeneity in keratin thickness, there was substantial inter-individual variation seen in all regions. Measurements made by the two laboratories showed high correlation (r = 0.741, 95% CI, 0.533–0.864). We conclude that, despite inter- and intra-individual variability, keratin thickness was similar in the inner and outer foreskin of healthy Ugandan men, and that reduced keratin thickness is not likely to make the inner foreskin more susceptible to HIV acquisition.
Archive | 1999
Robert J. Kelly; Noah Kiwanuka; Maria J. Wawer; David Serwadda; Nelson K. Sewankambo; Fred Wabwire-Mangen; Li Cj; Chuanjun Li; Joseph K. Konde Lule; Tom Lutalo; Fred Makumbi; Ronald H. Gray
Archive | 2004
Michael A. Koenig; Iryna Zablotska; Tom Lutalo; Fred Nalugoda; Jennifer A. Wagman; Ronald H. Gray; Christina C. Pallitto
Archive | 2016
François Blanquart; Mary K. Grabowski; Joshua T. Herbeck; Fred Nalugoda; David Serwadda; Michael A. Eller; Merlin L. Robb; Ronald H. Gray; Godfrey Kigozi; Oliver Laeyendecker; Katrina A. Lythgoe; Gertrude Nakigozi; Thomas C. Quinn; Steven J. Reynolds; Maria J. Wawer; Christophe Fraser
Archive | 2015
Tom Lutalo; Ronald H. Gray; Sanyukta Mathur; Maria J. Wawer; David Guwatudde; John S. Santelli; Fred Nalugoda; Fredrick Makumbi
Archive | 2015
Ashley C. Schuyler; Zoe R. Edelstein; Sanyukta Mathur; Joseph Sekasanvu; Fred Nalugoda; Ronald H. Gray; Maria J. Wawer; David Serwadda; John S. Santelli
Archive | 2013
Victor Pena-Cruz; Behzad Etemad; Nikolaos Chatziandreou; Phyu Hninn Nyein; Shannon Stock; Steven J. Reynolds; Ronald H. Gray; Thomas C. Quinn; Manish Sagar
Archive | 2012
Chelsea B. Polis; Gertrude Nakigozi; Victor Ssempijja; Fredrick Makumbi; Iga Boaz; Steven J. Reynolds; Anthony Ndyanabo; Tom Lutalo; Maria J. Wawer; Ronald H. Gray
Archive | 2011
Chelsea B. Polis; Ronald H. Gray; Tom Lutalo; Fred Nalugoda; Joseph Kagaayi; Godfrey Kigozi; Noah Kiwanuka; David Serwadda; Maria J. Wawer